Skip to content

MDMA: all studies

Page 97 of 346: studies 961 to 970 of 3,454, newest first. Back to the MDMA overview

Research

Increased cortisol levels in hair of recent Ecstasy/MDMA users.

European Neuropsychopharmacology March 1, 2014 Andrew C. Parrott, H. Sands, Lewis Jones et al. 35 citations

Previous research has revealed an acute 8-fold increase in salivary cortisol following self-administrated Ecstasy/MDMA in dance clubbers. It is currently not known to what extent repeated usage impacts upon activity of the hypothalamic-pituitary-adrenal axis over a more prolonged period of time. This study investigated the integrated cortisol levels in 3-month hair samples from recent...

A reconsideration and response to Parrott AC (2013) "Human psychobiology of MDMA or 'Ecstasy': an overview of 25 years of empirical research".

Human Psychopharmacology: Clinical and Experimental March 1, 2014 Rick Doblin, George Greer, Julie Holland et al. 48 citations

Parrott recently published a review of literature on MDMA/ecstasy. This commentary is a response to the content and tenor of his review, which mischaracterizes the literature through misstatement and omission of contrary findings, and fails to address the central controversies in the literature. The review makes several erroneous statements concerning MDMA-assisted psychotherapy, such as...

DOI: 10.1002/hup.2389 (opens in new tab) MDMA Ecstasy Therapeutic potential Controlled therapeutic contexts +6

In abstinent MDMA users the cortisol awakening response is off-set but associated with prefrontal serotonin transporter binding as in non-users

The International Journal of Neuropsychopharmacology February 14, 2014 Vibe G. Frøkjær, David Erritzøe, Klaus K. Holst et al. 19 citations

Serotonergic signaling is considered critical for an appropriate adaptation to stress. We have previously observed that in healthy volunteers, prefrontal serotonin transporter (SERT) binding is positively associated with hypothalamic-pituitary-adrenal (HPA)-axis output in terms of the cortisol awakening response (CAR). Here, we tested (1) if such a correlation persists in a human model of...

DOI: 10.1017/s1461145714000066 (opens in new tab) Full text (opens in new tab) MDMA Serotonin transporter Clinical psychology Receptor

MDMA decreases the effects of simulated social rejection.

Pharmacology, Biochemistry, and Behavior February 2014 Charles G Frye, Margaret C. Wardle, Greg J Norman et al.

3-4-Methylenedioxymethamphetamine (MDMA) increases self-reported positive social feelings and decreases the ability to detect social threat in faces, but its effects on experiences of social acceptance and rejection have not been determined. We examined how an acute dose of MDMA affects subjective and autonomic responses to simulated social acceptance and rejection. We predicted that MDMA would...

DOI: 10.1016/j.pbb.2013.11.030 (opens in new tab) Full text (opens in new tab) MDMA Cyberball Respiratory sinus arrhythmia Social cognition

"Ecstasy"-induced toxicity in SH-SY5Y differentiated cells: role of hyperthermia and metabolites.

Archives of Toxicology February 2014 Daniel José Barbosa, João Paulo Capela, Renata Silva et al.

3,4-Methylenedioxymethamphetamine (MDMA; "ecstasy") is a recreational hallucinogenic drug of abuse known to elicit neurotoxic properties. Hepatic formation of neurotoxic metabolites is thought to play a major role in MDMA-related neurotoxicity, though the mechanisms involved are still unclear. Here, we studied the neurotoxicity mechanisms and stability of MDMA and 6 of its major human...

Depression, impulsiveness, sleep, and memory in past and present polydrug users of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy).

Psychopharmacology February 2014 Lynn Taurah, Chris Chandler, Geoff Sanders

Ecstasy (3,4-methylenedioxymethamphetamine, MDMA) is a worldwide recreational drug of abuse. Unfortunately, the results from human research investigating its psychological effects have been inconsistent. The present study aimed to be the largest to date in sample size and 5HT-related behaviors; the first to compare present ecstasy users with past users after an abstinence of 4 or more years,...

How MDMA's Pharmacology and Pharmacokinetics Drive Desired Effects and Harms

The Journal of Clinical Pharmacology January 16, 2014 C. Michael White 58 citations

Abstract 3,4‐Methylenedioxymethamphetamine (MDMA) is an agent of abuse that has been used by over 16 million Americans. Increased energy, elevated mood, bonding with others, and psychedelic effects are desired effects while liver damage, extended depressed mood, sexual assault, rhabdomyolysis, serotonin syndrome, multiorgan failure, cardiovascular events, arrhythmias, and death are possible...

The Effects of Acutely Administered 3,4-Methylenedioxymethamphetamine on Spontaneous Brain Function in Healthy Volunteers Measured with Arterial Spin Labeling and Blood Oxygen Level–Dependent Resting State Functional Connectivity

Biological Psychiatry January 10, 2014 Robin Carhart-Harris, Kevin Murphy, Robert Leech et al. 182 citations

The MTLs appear to be specifically implicated in the mechanism of action of MDMA, but further work is required to elucidate how the drug's characteristic subjective effects arise from its modulation of spontaneous brain activity.

DOI: 10.1016/j.biopsych.2013.12.015 (opens in new tab) MDMA Euphoriant Cerebral blood flow Amygdala +5

Behavioral and neurochemical effects of repeated MDMA administration during late adolescence in the rat.

Progress in Neuro-Psychopharmacology and Biological Psychiatry January 3, 2014 Brittney M Cox, Mrudang M Shah, Teri Cichon et al.

Adolescents and young adults disproportionately abuse 3,4-methylenedioxymethamphetamine (MDMA; 'Ecstasy'); however, since most MDMA research has concentrated on adults, the effects of MDMA on the developing brain remain obscure. Therefore, we evaluated place conditioning to MDMA (or saline) during late adolescence and assessed anxiety-like behavior and monoamine levels during abstinence. Rats...

The effect of MDMA-induced anxiety on neuronal apoptosis in adult male rats' hippocampus.

Folia biologica 2014 S Karimi, M Jahanshahi, M J Golalipour

Ecstasy or MDMA as a psychoactive drug and hallucinogen is considered one of the most commonly used drugs in the world. This psychotropic substance is discussed both as sexually stimulating and reducing fear and anxiety. Amphetamines also destroy neurons in some brain areas. The aim of this study was to investigate the effects of MDMA on anxiety and apoptosis of hippocampal neurons. Forty-two...